20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Autoimmune Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alaeddine, LM; Azar, NS; Dia, B; Eid, AA; El Khoury, M; Hamza, M; Harb, F; Mogharbil, N; Noureldein, MH; Sabra, R | 1 |
| Ćosić, A; Drenjančević, I; Mihalj, M; Mišir, M; Novak, S; Renić, M; Vesel, M | 1 |
| Abboud, HE; Barnes, JL; Block, K; Eid, AA; Fagg, BM; Gorin, Y; Maalouf, R | 1 |
3 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Autoimmune Diabetes
| Article | Year |
|---|---|
Pharmacological regulation of cytochrome P450 metabolites of arachidonic acid attenuates cardiac injury in diabetic rats.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Cardiomyopathies; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Hydroxyeicosatetraenoic Acids; Male; NADPH Oxidase 4; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Streptozocin | 2021 |
Hyperbaric oxygenation and 20-hydroxyeicosatetreanoic acid inhibition reduce stroke volume in female diabetic Sprague-Dawley rats.
Topics: Amidines; Animals; Aryl Hydrocarbon Hydroxylases; Brain; Combined Modality Therapy; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Cytochrome P450 Family 4; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Epoxide Hydrolases; Female; Gene Expression Regulation, Enzymologic; Hydroxyeicosatetraenoic Acids; Hyperbaric Oxygenation; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Nitric Oxide Synthase Type III; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; Steroid 16-alpha-Hydroxylase; Time Factors | 2017 |
Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.
Topics: Animals; Cytochrome P-450 CYP4A; Diabetes Mellitus, Type 1; Disease Models, Animal; Enzyme Induction; Enzyme Inhibitors; Glucose; Hydroxyeicosatetraenoic Acids; Mice; Mice, Mutant Strains; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 4; NADPH Oxidases; Podocytes; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2009 |